Biotech | August 10, 2021
Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
Nearly 6,000 patients have been treated with the drug since 2017
Company working on COVID vaccine INO 4800
A veteran in cell therapy and oncology commercialisation
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
All India Institute of Ayurveda hosts ministers and showcase their achievements
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
The goal for the project is the identification and optimization of anti-viral compounds.
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Subscribe To Our Newsletter & Stay Updated
